Skip to main content
SpringerLink
Log in

Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

Studies have demonstrated that smokers have lower levels of brain monoamine oxidase (MAO) A and B activity and lower MAO-B platelet activity than non-smokers. Recent speculations suggest that in addition to nicotine, tobacco components which are MAO inhibitors, may contribute to some tobacco related psychopharmacological effects. Furthermore, epidemiological evidence indicates a lower incidence of Parkinson’s disease in smokers than in non-smokers. This relationship also might be linked to MAO inhibition. There intriguing observations prompted studies on the effects of tobacco leaf and tobacco smoke constituents on MAO activity. Studies reported here demonstrate that crude hexane tobacco leaf and hexane and aqueous leaf extracts have MAO inhibitory properties. Rat brain mitochondrial MAO-A and MAO-B activity are not altered following continuous 28 day exposure (osmotic minipump) to two tobacco alkaloids, (S)-nicotine or (R,S)-N-methylanatabine. However, earlier studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated parkinsonian C57BL/6 mouse model have provided indirect evidence that the tobacco derived 2,3,6-trimethyl-1,4-naphthoquinone (an MAO-A and B inhibitor) is effective in inhibiting MAO-B in vivo and is neuroprotective. Results reported here from more extensive tobacco leaf extractions provide evidence for three additional compounds with MAO-B inhibitory properties. One contains a chromone system, another a polyunsaturated macrocycle and the third we have identified as farnesylacetone. These findings provide support to the thesis that components of tobacco smoke may be responsible for the inhibition of brain MAO-A and brain and platelet MAO-B in human smokers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Backwell, E.R.C. and Williams, C.H. (1987) “Radiolabeled clorgyline and L-deprenyl—suicide inactivators of monoamine oxidase,” Biochem. Soc. Trans. 15, 246–247.

    CAS  Google Scholar 

  • Bai, H. (1991) Synthetic and Metabolic Studies on 1-Methyl-4-(1-methylpyrrol-2-yl)-1,2,3,6-tetrahydropyridine, a Neurotoxic Analog of the Parkinsonian Inducing Agent MPTP. MS Thesis, Virginia Tech, Blacksburg, VA, pp. 16–23.

    Google Scholar 

  • Behmand, R.A. and Harik, S.I. (1992) “Nicotine enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity,” J. Neurochem. 58, 776–779.

    Article  PubMed  CAS  Google Scholar 

  • Berlin, J., Said, S., Spreux-Varoquaux, O., Launay, J.M., Livares, R., Millet, V., Lecrubier, Y. and Puech, A.J. (1995a) “A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers,” Clin. Pharmacol. Ther. 58, 44–452.

    Article  Google Scholar 

  • Berlin, K., Said, S., Spreux-Varoquaux, O., Olivares, R., Launay, J.M. and Puech, A.J. (1995b) “Monoamine oxidase A and B activities in heavy smokers,” Biol. Psychiatry 38, 756–761.

    Article  PubMed  CAS  Google Scholar 

  • Berlin, I. and Anthenelli, R.M. (2001) “Monoamine oxidases and tobacco smoking,” International J. of Neuropsychopharmacology 4, 33–42.

    CAS  Google Scholar 

  • Bradford, M.M. (1976) “A rapid and sensitive method of the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding,” Anal. Biochem. 72, 248–254.

    Article  PubMed  CAS  Google Scholar 

  • Carr, L.A. and Basham, J.K. (1991) “Effects of tobacco smoke constituents on MPTP-induced toxicity and monoamine oxidase activity in the mouse brain,” Life Sci. 48, 1173–1177.

    Article  PubMed  CAS  Google Scholar 

  • Castagnoli, K., Palmer, S., Anderson, A., Bueters, T. and Castagnoli, Jr N. (1997) “The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine,” Chem. Res. Toxicol. 10, 364–368.

    Article  PubMed  CAS  Google Scholar 

  • Castagnoli, K., Palmer, S. and Castagnoli, Jr. N. (1999) “Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity,” Neurobiology 7, 135–149.

    PubMed  CAS  Google Scholar 

  • Castagnoli, K.P., Steyn, S.J., Petzer, J.P., Van der Schyf, C.J. and Castagnoli, Jr. N. (2001) “Neuroprotection in the MPTP parkinsonian C57BL/6 mouse model by a compound isolated from tobacco,” Chem. Res. Toxicol. 14, 523–527.

    Article  PubMed  CAS  Google Scholar 

  • Chamberlain, W.J. and Stedman, R.L. (1986) “Composition studies on tobacco. XXVIII. 2,3,6-Trimethyl-1,4-naphthoquinone in cigarette smoke,” Phytochemistry 7, 1201–1203.

    Article  Google Scholar 

  • Chiba, K., Peterson, L.A., Castagnoli, K.P., Trevor, A.J., and Castagnoli, jr. N. (1985) “Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP),” Drug Metab. Dispos., 13, 342–347.

    PubMed  CAS  Google Scholar 

  • Costa, G., Abin-Carriquiry, J.A., and Dajas, F. (2001) “Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra,” Brain Res 888, 336–342.

    Article  PubMed  CAS  Google Scholar 

  • Deo, N.M. and Crooks, P.A. (1996) “Regioselective alkylation of N-(diphenylmethylidine)-3-aminomethylpyridine: a a simple route to minor tobacco alkaloids and related compounds,” Tetrahedron Letters 37, 1137–1140.

    Article  CAS  Google Scholar 

  • Di Monte, D.A., Royland, J.E., Anderson, A., Castagnoli, K., Castagnoli, Jr, N. and Langston, J.W. (1997) “Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity,” J. Neurochem. 69, 1771–1773.

    Article  PubMed  Google Scholar 

  • Essman, W.B. (1977) “Serotonin and monoamine oxidase in mouse skin: effects of cigarette smoke exposure,” J. Medicine 8, 95–101.

    CAS  Google Scholar 

  • Ferger, B., Spratt, C., Earl, C.D., Teismann, P., Oertel, W.H. and Kuschinsky, K. (1998) “Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo,” Naunyn Schmiedebergs Arch. Pharmacol. 358, 351–359.

    Article  PubMed  CAS  Google Scholar 

  • Flaherty, P., Castagnoli, K., Wang, Y-X. and Castagnoli, Jr. N. (1996) “Synthesis and selective monoamine oxidase B-inhibiting properties of 1-methyl-1,2,3,6-tetrahydropyrid-4-yl carbamate derivatives: Potential prodrugs of (R)- and (S)-nordeprenyl”, J. Med. Chem. 39, 4756–4761.

    Article  PubMed  CAS  Google Scholar 

  • Fowler, J.S., Volkow, N.D., Wang, G.J., Pappas, N., Logan, J., Shea, C., Alexoff, D., MacGregor, R., Schlyer, D., Zezulkova, I. and Wolf, A.P. (1996a) “Brain monoamine oxidase A inhibition in cigarette smokers,” Proc. Natl. Acad. Sci. USA 93, 14065–14069.

    Article  PubMed  CAS  Google Scholar 

  • Fowler, J.S., Volkow, N.D., Wang, G.J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Shea, C., Schlyer, D. and Wolf, A.P., (1996b) “Inhibition of monoamine oxidase B in the brains of smokers,” Nature 379, 733–736.

    Article  PubMed  CAS  Google Scholar 

  • Fowler, J.S., Volkow, N.D., Logan, J., Pappas, N., King, P., MacGregor, R., Shea, C., Garza, V. and Gatley, S.J. (1998) “An acute dose of nicotine does not inhibit MAO B in baboon brain in vitro,” Life Sci. 63, 19–23.

    Article  Google Scholar 

  • Fuller, R.W. and Henrick-Luecke, S.K. (1984) “Deprenyl protection against striatal dopamine depletion by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice,” Res. Commun. Subst. Abuse 5, 241–246.

    CAS  Google Scholar 

  • Fung, Y.K., Fiske, L.A. and Lau, Y.S. (1991) “Chronic administration of nicotine fails to alter the MPTP-induced neurotoxicity in mice,” Gen. Pharmacol. 22, 669–672.

    PubMed  CAS  Google Scholar 

  • Gao, S.G., Cui, W.Y., Shang, H.T. and Liu, C.G. (1998) “Effects of nicotine on 1-methyl-4-phenyl-1,2,5,6,-tetrahydropyridine-induced depression of striatal dopamine content and spontaneous locomotor activity in C57 black mice,” Pharmacol Res. 38, 101–106.

    Article  PubMed  CAS  Google Scholar 

  • Hadjiconstantinou, M., Hubble, J.P., Wemlinger, T.A., Neff, N.H.. and Enhanced, M.P.T.P. (1994) “Neurotoxicity after treatment with isoflurophate or cholinergic agonists,” J. Pharmacol. Exp. Ther. 270, 639–644.

    PubMed  CAS  Google Scholar 

  • Hauptman, N. and Shih, J.C.2-N. (2001) “Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity,” Life Sci. 68, 1231–1241.

    Article  Google Scholar 

  • Heikkila, R.E., Manzino, L., Cabbat, F.S. Duvoisin, R.C. (1984) “Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,5-tetrahydropyridine by monoamine oxidase inhibitors,” Nature 311, 467–469.

    Article  PubMed  CAS  Google Scholar 

  • Inoue, H., Castagnoli, K., Van der Schyf, C., Mabic, S., Igarashi, K. and Castagnoli, Jr. N. (1999) “Species dependent differences in the monoamine oxidase A and B catalyzed oxidation of various C-4 substituted 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridinyl derivatives,” J. Pharmacol. Exp. Ther. 291, 856–864.

    PubMed  CAS  Google Scholar 

  • Jacob, III, P., Ulgen, M. and Gorrod, J.W. (1997) “Metabolism of (−)-(S)-nicotine by guinea pig and rat brain: identification of cotinine,” European J. of Drug Metabolism and Pharmacokinetics 22, 391–394.

    CAS  Google Scholar 

  • James, H., Yousef, T. and Taylor, R. (1998) “Rapid method for the simultaneous measurement of nicotine and cotinine in urine and serum by gas chromatography-mass spectrometry,” J. Chromatogr. B. Biomed. Sci. Appli. 708, 87–93.

    Article  CAS  Google Scholar 

  • Janson, A.M., Fuxe, K., Sundstrom, E., Agnati, L.F. and Goldstein, M. (1988) “Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse,” Acta Physiol. Scand. 132, 589–591.

    Article  PubMed  CAS  Google Scholar 

  • Janson, A.M., Fuxe, K. and Goldstein, M. (1992) “Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse,” Clin. Investig. 70, 232–238.

    Article  PubMed  CAS  Google Scholar 

  • Kimpland, B., Appleton, A.J., Aasen, A.J., Roseraade, J. and Enzell, C.R. (1972) “Neutral oxygen-containing volatile constituents of Greek tobacco,” Phytochemistry 11, 309–316.

    Article  Google Scholar 

  • Khalil, A.A., Steyn, S. and Castagnoli, Jr. N. (2000) “Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves,” Chem. Res. Toxicol. 13, 31–35.

    Article  PubMed  CAS  Google Scholar 

  • Maggio, R., Riva, M., Vaglini, F., Fornai, F., Racagni, G. and Corsini, G.U., (1997) “Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism,” J. Neural Transm. 104, 1113–1123.

    Article  PubMed  CAS  Google Scholar 

  • Morens, D.M., Grandinetti, A., Reed, D., White, L.R. and Ross, G.W., (1995) “Cigarette smoking and protection from Parkinson’s disease: False association or etiologic clue?,” Neurology 45, 1041–1051.

    PubMed  CAS  Google Scholar 

  • Norman, T.R., Chamberlain, K.G., French, M.A. and Burrows, G.D. (1982) “Platelet monoamine oxidase activity and cigarette smoking,” J. Affective Disorders 4, 73–77.

    Article  CAS  Google Scholar 

  • Norman, T.R., Chamberlain, K.G. and French, M.A. (1987) “Platelet monoamine oxidase: Low activity in cigarette smokers,” Psychiatry Res. 20, 199–205.

    Article  PubMed  CAS  Google Scholar 

  • Oreland, L., Fowler, C.J. and Schalling, D. (1981) “Low platelet monoamine oxidase activity in cigarette smokers,” Life Sci. 29, 2511–2518.

    Article  PubMed  CAS  Google Scholar 

  • Parain, K., Marchand, V., Dumery, B. and Hirsch, E. (2001) “Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice,” Brain Res. 890, 347–350.

    Article  PubMed  CAS  Google Scholar 

  • Pitts, S.M., Markey, X.P., Murphy, D.L. and Weisz, A. (1986) “Recommended practices for the safe handling of MPTP”, In: Markey, S.P., Castagnoli, Jr. N., Trevor, A.J., and Kopin, I.J., eds, MPTP: A Neurotoxin Producing a Parkinsonian Syndrome (Academic Press, New York), pp 703–716.

    Google Scholar 

  • Ryan, R.E., Ross, S.A., Drago, J. and Loiacono, R.E. (2001) “Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice,” Br. J. Pharmacol. 132, 1650–1656

    Article  PubMed  CAS  Google Scholar 

  • Salach, J.I. and Weyler, W. (1987) “Preparation of the flavin-containing aromatic amine oxidases of human placenta and beef liver,” Methods Enzymol. 142, 627–637.

    Article  PubMed  CAS  Google Scholar 

  • Schmidle, C.J. and Mansfield, R.C. (1956) “The aminomethylation of olefins. II. A new synthesis of 1-alkyl-4-aryl-4-piperidinols” J. Am. Chem. Soc. 78, 425–428.

    Article  CAS  Google Scholar 

  • Shigenaga, M. (1989) Studies on the Metabolism and Bioactivation of (S)-Nicotine and Beta-Nicotyrine. PhD thesis University of California San Francisco, San Francisco, CA, pp. 162–166.

  • Sershen, H., Mason, M.R., Reith, M.E., Hashim, A. and Lajtha, A. (1986) “Effect of nicotine and amphetamine on the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice,” Neuropharmacology 25, 1231–1234

    Article  PubMed  CAS  Google Scholar 

  • Sershen, H., Hashim, A. and Lajtha, A. (1987) “Behavioral and biochemical effects of nicotine in an MPTP-induced mouse model of Parkinson’s disease,” Pharmacol. Biochem. Behav. 28, 299–303.

    Article  PubMed  CAS  Google Scholar 

  • Sershen, H., Hashim, A., Wiener, H.L. and Lajtha, A. (1988) “Effect of chronic oral nicotine on dopaminergic function in the MPTP-treated mouse,” Neurosci. Lett. 93, 270–274.

    Article  PubMed  CAS  Google Scholar 

  • Simpson, G.M., Shih, J.C., Chen, K., Flowers, C., Kumazawa, T. and Spring, B. (1999) “Schizophrenia, monoamine oxidase activity, and cigarette smoking,” Neuropsychopharmacology 4, 392–394.

    Article  Google Scholar 

  • Spath, E. and Kesztler, F. (1937) “Tobacco alkaloids, XIII. New tobacco bases,” Ber. 70B, 2450–2454.

    CAS  Google Scholar 

  • Vaglini, F., Fascetti, F., Tedeschi, D., Cavalletti, M., Fornai, F. and Corsini, G.U. (1996) “Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice,” Neurodegeneration 5, 129–136.

    Article  PubMed  CAS  Google Scholar 

  • Yong, V.W. and Perry, T.L. (1986) “Monoamine oxidase B, smoking, and Parkinson’s Disease,” J. Neurological Sci. 72, 265–272.

    Article  CAS  Google Scholar 

  • Youngster, S.K., McKeown, K.A., Jin, Y.Z., Ramsay, R.R., Heikkila, R.E., and Singer, T.P. (1989) “Oxidation of analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidases A and B and the inhibition of monoamine oxidases by the oxidation products,” J. Neurochem. 53, 1837–1842.

    Article  PubMed  CAS  Google Scholar 

  • Yu, P.H. and Boulton, A.A. (1987) “Irreversible inhibition of monoamine oxidase by some components of cigarette smoke,” Life Sci. 41, 675–682.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Stefanus J. Steyn

    Present address: Pfizer Pharmaceuticals, Drug Metabolism, Groton, CT, USA

  2. Geraldine Magnin

    Present address: Chemical Toxicology, Veterinary Medicine, Virginia Tech, Virginia, USA

  3. Ashraf Khalil

    Present address: College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

Authors and Affiliations

  1. Harvey W. Peters Center, Department of Chemistry, Virginia Tech, 24061-0212, Blacksburg, VA, USA

    Kay Castagnoli, Stefanus J. Steyn, Geraldine Magnin, Cornelis J. Van Der Schyf, Izel Fourie, Ashraf Khalil & Neal Castagnoli

  2. Department of Biomedical Sciences and Pathobiology, Virginia Tech, 24061-0212, Blacksburg, VA, USA

    Cornelis J. Van Der Schyf

Authors
  1. Kay Castagnoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefanus J. Steyn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Geraldine Magnin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cornelis J. Van Der Schyf
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Izel Fourie
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ashraf Khalil
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Neal Castagnoli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kay Castagnoli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Castagnoli, K., Steyn, S.J., Magnin, G. et al. Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase. neurotox res 4, 151–160 (2002). https://doi.org/10.1080/10298420290015854

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1080/10298420290015854

Keywords

Search

Navigation